We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Slade

David H. Slade MD

Assistant Professor, Infectious Disease, Loyola University Medical Center, Maywood, Illinois

Dr. Slade earned his MD/JD from Southern Illinois University, with a focus on health law and health policy. He is an assistant professor of infectious disease at Loyola University Medical Center. Dr. Slade is co-chair of the Trinity Health infection prevention and control COVID-19 action committee, served on the Trinity Health COVID-19 Screening Technology Steering Team, serves as a member of the Loyola infection control and prevention committee, and is a member of the Loyola and Hines VA antibiotic stewardship committees. Dr. Slade practices general infectious disease with a focus on HIV care, and is the medical director of the outpatient parenteral antimicrobial therapy (OPAT) program. 

Disclosures

Dr. Slade is local site principal investigator, Passive Immunity Trial for Our Nation to Treat COVID-19 in hospitalized patients clinical trial, examining the safety and efficacy of convalescent donor plasma to treat COVID-19 in hospitalized adults in a randomized, placebo-controlled setting.